Top Abstract Purchase Related
Home
>
Node
>
Subnode

Potentiation of the anticoagulant effects of a phosphatidylserine-containing anticoagulant and heparin

Byshevskiĭ, A.S.; Sokolovskiĭ, S.R.

Voprosy Meditsinskoi Khimii 28(2): 30-34

1982

ISSN/ISBN: 0042-8809
PMID: 7080476
Document Number: 192620
Phosphatidylserine containing anticoagulant and heparin mutually increased their anticoagulating activity under conditions of simultaneous treatment in vitro and in vivo. The rate of the potentiation effect depended on a dosage and, apparently, on the ratio of these anticoagulants. The lipid did not react with heparin as shown by spectrophotometric and gel filtration methods as well as by extraction of 131I-phosphatidylserine with chloroform and sedimentation by means of high speed centrifugation. The data obtained suggest that the potentiating effect of the anticoagulants was not due to formation of a complex exhibiting new properties but was caused by effects of these substances at various steps of blood coagulation process.

Document emailed within 1 workday
Secure & encrypted payments

Chabanov, M.K. 1981: Mechanism of the hypocoagulemic effect and the active principle of a phosphatidylserine-containing anticoagulant Farmakologiia i Toksikologiia 44(4): 425-428
Harenberg, J.; Stehle, G.; Dempfle, C.E.; von Hodenberg, E.; Heene, D.L. 1989: The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects Folia Haematologica 116(6): 967-980
Bychko, S.M.; Kharlamova, V.N. 1975: The anticoagulant properties of different heparin fractions Biulleten' Eksperimental'noi Biologii i Meditsiny 79(2): 61-63
Dalmora, S.L.; Assaf, G.S.; Dalmora, M.E.; Vaucher, L.C.; Vaccari, S.F. 1991: Determination of anticoagulant activity of heparin Revista do Hospital das Clinicas 46(2): 59-62
Bremmelgaard, A. 1986: Heparin and monitoring of peroral anticoagulant therapy Ugeskrift for Laeger 148(21): 1275-1276
Ofosu, F.A. 1988: Mechanisms for the anticoagulant effect of heparin and related polysaccharides Nouvelle Revue Francaise d'Hematologie 30(3): 155-160
Krupiński, K.; Bielawiec, M.; Breddin, H.K. 1994: Antithrombotic properties of heparin independent of its anticoagulant activity Acta Haematologica Polonica 25(3): 243-251
Kudriashov, B.A.; Liapina, L.A.; Azieva, L.D. 1990: The content of a heparin-like anticoagulant in the flowers of the meadowsweet (Filipendula ulmaria) Farmakologiia i Toksikologiia 53(4): 39-41
Matsuoka, T.; Inoue, K.; Mizuno, K.; Kita, Y.; Nakanishi, S.; Asai, S.; Taoka, R.; Soda, T.; Terai, A. 2012: Heparin as bridging anticoagulant and antiplatelet therapy during the perioperative period Hinyokika Kiyo. Acta Urologica Japonica 58(5): 223-226
Millot, F.; Bara, L.; Etienne, J.; Samama, M.; Laruelle, P. 1987: Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives Nouvelle Revue Francaise d'Hematologie 29(6): 397-400
Strukova, S.M.; Khlebnikova, T.G.; Umarova, B.A.; Kulibali, M. 1984: Heparin secretion by mast cells as an index of the status of the anticoagulant system Biulleten' Eksperimental'noi Biologii i Meditsiny 97(2): 131-134
Shammas, N.W.; Lemke, J.H.; Dippel, E.J.; McKinney, D.E.; Takes, V.S.; Youngblut, M.; Harris, M.; Harb, C.; Kapalis, M.J.; Holden, J. 2003: In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant Journal of Invasive Cardiology 15(5): 242-246
Schneider, T.; Heuer, B.; Deller, A.; Boesken, W.H. 2000: Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II) Wiener Klinische Wochenschrift 112(12): 552-555
Völker, W.; Böhm, A.; Schmidt, A.; Svahn, C.M.; Gellerbring, A.K.; Mattsson, C.; Ekvärn, S.; Robenek, H.; Buddecke, E. 1995: Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparin Arzneimittel-Forschung 45(5): 546-550
Burg, M.; Ostendorf, T.; Mooney, A.; Koch, K.M.; Floege, J. 1997: Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety Laboratory Investigation; A Journal of Technical Methods and Pathology 76(4): 505-516
Pomortseva, I.V.; Ovchinnikova, L.K.; Shcheglova, N.V. 1990: The influence of the Soviet antimalarial preparation dabequin on the hemostatic system and on the anticoagulant effect of heparin Farmakologiia i Toksikologiia 53(1): 59-62
Shah, A.C.; Genoni, M.; Niederhäuser, U.; Maloigne, M.; Turina, M. 2000: R-hirudin (lepirudin, refludan) as an alternative anticoagulant in heparin-induced thrombocytopenia during cardiopulmonary bypass connection Schweizerische Medizinische Wochenschrift 130(23): 896-899
Patel, A.A.; White, C.M.; Coleman, C.I. 2007: Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention Connecticut Medicine 71(2): 93-95
Ushkalova, E.A.; Kremneva, V.F.; Ovchinnikova, L.K.; Shcheglova, N.V. 1989: Comparative evaluation of the anticoagulant activity of the sodium and calcium salts of heparin, isolated from swine intestinal mucosa Farmakologiia i Toksikologiia 52(3): 51-55
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s